CannabisNewsBreaks Archive - Page 120 of 420

MondayDec 21, 2020 12:18 pm

CannabisNewsBreaks – CannAssist International Corporation’s (CNSC) Xceptol Brand Available via Innovative Distribution Portal – RangeMe

CannAssist (OTCQB: CNSC) today announced approval of its Xceptol brand on the distribution website RangeMe. According to the update, RangeMe added Xceptol drops and capsules to the Xceptol pain cream products already available, bringing the number of Xceptol SKUs on the platform to 10. Additional SKUs will be added in the first quarter of 2021. RangeMe's broad network creates a significant new revenue source for CannAssist International. "This is exciting news for us on many fronts; a process estimated to take weeks was accomplished in a few days – a testament, I feel, to the quality of the Xceptol brand,"…

ThursdayDec 17, 2020 11:30 am

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) to ‘Launch into 2021 with Various Exciting Projects’

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced an update for its first successful 100-acre pilot outdoor hemp CBD harvest. According to the update, the harvest yielded a quality much higher than the company’s expectations, and a yield of over 105,000 lbs in total biomass was prepared for sale and processing to Speakeasy Cannabis Club (CSE: EASY). "We are very proud of our team and partners at Rock Creek Farms who have been committed to the vision and dedicated to achieving success," said Pac Roots president and…

WednesdayDec 16, 2020 3:16 pm

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Commences Trading on the OTCQB Venture Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that it has commenced trading in the United States on the OTCQB Venture Market under the symbol "PACRF." The company anticipates that its new U.S. listing will provide greater liquidity and a more seamless trading experience for its U.S. shareholders and potential investors. "With the cannabis industry gaining momentum in the United States, this cross-border listing will increase our visibility and open the doors to new investors as well as enable exciting business opportunities," said Pac Roots president and…

WednesdayDec 16, 2020 2:31 pm

CannabisNewsBreaks – Why CannAssist International Corporation (CNSC) Is ‘One to Watch’

CannAssist (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol ("CBD") products under the Xceptol brand. A recent article discussing the company reads, “Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CNSC founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products.” To view the full article, visit https://cnw.fm/EKrzX…

WednesdayDec 16, 2020 11:40 am

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Announces Progress in Commercialization Plan with Initial Product Expected in Q1 2021

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) has contracted with a leading manufacturer to produce its first cannabinoid, cannabigerol ("CBG"); the first production run is slated for early 2021 and will result in commercial quantities of Willow’s ultra-pure CBG. The product will be manufactured in Europe. In addition, Willow announced plans to run a second 500-litre pilot this month in order to meet demand for customer samples and streamline the production process. These announcements mark significant progress for the company in its strategic commercialization plan. Based on progress so far, the company noted that it anticipates seeing revenue generated from this…

TuesdayDec 15, 2020 3:58 pm

CannabisNewsBreaks – Gage Cannabis Co. on Rapid Growth Trajectory, Looks to Cultivate Additional Opportunity in Michigan

Gage Cannabis, a premium adult-use cannabis retailer, is set to capitalize on stunning growth of the Michigan industry. Ever since recreational use was legalized in 2018, Michigan has become one of the fastest-growing legal cannabis markets in the United States in terms of consumption. In fact, state authorities have recently projected recreational marijuana sales to be worth nearly $1 billion per annum in 2021 with revenues set to reach over $1.5 billion by 2023 (https://www.cnw.fm/rAUw9). An article discussing the company’s positioning amid this budding market reads, “Gage Cannabis has witnessed a rapid growth trajectory since its inception, having opened its…

TuesdayDec 15, 2020 2:36 pm

CannabisNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Announces Entry into Cannabis Productivity, Plans for Psychedelic Research and Development

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately held biopharma company, today announced its entry into the productivity phase of cannabis cultivation, micropropagation and extraction. The company also announced its preparation of a Health Canada application towards psychedelic research and development for a medicinal mushroom (Psilocybe semilanceata) Dealer Licence and a Section 56 Exemption for use of psilocybin production and extraction for planned preclinical research under scientific purposes, per the Controlled Drugs and Substances Act (the “CDSA”). According to the update, W2G has secured approval for a single-story production facility designed to support tissue culture and micropropagation and to meet organic…

TuesdayDec 15, 2020 10:52 am

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Notes Appreciation for Health Canada Milestone Special Access Programme

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has voiced its support and appreciation for Health Canada’s recently announced Special Access Programme (“SAP”) for psilocybin-assisted psychotherapy inclusion. The government entity recently announced its intent to revise the SAP and other related regulations to allow limited uses of psilocybin-assisted psychotherapeutic treatments. The SAP revision may open the door to new medical applications in the mental health space and support the progress of advanced research initiatives, including ongoing clinical trials evaluating psilocybin-assisted psychotherapy. The proposed SAP update may also positively…

ThursdayDec 10, 2020 10:12 am

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Lays Groundwork for Move into World of Psychedelics

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, today announced its engagement of a globally recognized operations, compliance and regulatory consulting firm to advise on the company’s application to Health Canada for a Dealers Licence under the Controlled Drugs and Substances Act (“CDSA”). “Having the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis and other regulated consumer product industries assures that we will submit a fully-compliant Dealers Licence application to Health Canada in the shortest time possible,” said Pure Extracts…

TuesdayDec 08, 2020 12:30 pm

CannabisNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Secures Health Canada Approval for Standard Cultivation, Processing, Medical Sales

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately owned biopharma company, today announced its receipt of Health Canada’s approval for the standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations. According to the update, the licenses are effective as of Nov. 20, 2020. Valid for a three-year period, the terms of the licenses include approval of a single-story production facility designed to support micropropagation tissue culture, organic cultivation, processing and medical sales requirements. Phase II plans include expansion of the research laboratory and controlled cultivation rooms, as well as the addition of a medical dispensary. To view…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks